Literature DB >> 3377989

Carbimazole-induced immune haemolytic anaemia: role of drug-red blood cell complexes for immunization.

A Salama1, H Northoff, H Burkhardt, C Mueller-Eckhardt.   

Abstract

We report on a patient who developed acute intravascular immune haemolysis while receiving carbimazole. Serological studies revealed a strongly (3+) and a discretely positive (1+) direct antiglobulin test due to C3d and IgG respectively, and a very weak IgG autoantibody in the eluates. Serum from the patient contained specific carbimazole-dependent red blood cell (RBC) antibodies which reacted with all normal human RBC in the presence of free carbimazole as well as with RBC coated with the drug either in vitro or in vivo, although carbimazole itself is not detectable in plasma after oral administration. The results provide direct evidence for the sequence of the drug-RBC-antibody interaction and show that the RBC (and not plasma proteins) function as 'carrier-like' macromolecules in the immune response.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3377989     DOI: 10.1111/j.1365-2141.1988.tb04240.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies.

Authors:  Daniel W Bougie; Peter R Wilker; Richard H Aster
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

2.  Successful treatment of methimazole-induced severe aplastic anemia by granulocyte colony-stimulating factor, methylprednisolone, and cyclosporin.

Authors:  Munehiro Honda
Journal:  ISRN Endocrinol       Date:  2011-04-10

3.  Association of HLA-B and HLA-DRB1 polymorphisms with antithyroid drug-induced agranulocytosis in a Han population from northern China.

Authors:  Yayi He; Jie Zheng; Qian Zhang; Peng Hou; Feng Zhu; Jian Yang; Wenhao Li; Pu Chen; Shu Liu; Bao Zhang; Bingyin Shi
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.